Women from across the nation are giving of themselves to bring an end to the disease.
University of Illinois scientists just figured out how to make a great cancer-fighting drug even better: BTN LiveBIG
Tamoxifen is teaming up with Selinexor to take down breast cancer.
It’s Breast Cancer Awareness Month, and the pink ribbons (and shirts, and stickers) are out in force. And the Big Ten Cancer Research Consortium (BTCRC) is commemorating the month by highlighting innovative and important work the universities of the conference are doing year-round to fight this terrible disease. Read about some of that work below: University of Illinois Until now, the study of cancerous tumor cells is hindered by an important factor: environment. The most common tool for studying the growth and spread of a tumor has been a plastic plate that doesn’t mimic the human body. But recently, the
When someone tells Amanda Mercer she can’t do something, that’s exactly when she decides she’ll do it, no matter what. Mercer graduated from Michigan State in 1990, but her Spartan spirit is still strong, and it helps her face challenges every day. The most notable example of that spirit was Mercer’s record-breaking swim across the English Channel with five friends on July 27, 2012. They swam the 42 miles across the channel and back in a relay that lasted 18 hours and 55 minutes. That sounds like a long time — and it is, when you’re swimming in cold, choppy
It’s Breast Cancer Awareness Month, and new research from a University of Illinois medical team could redefine the role of estrogen in the development of this deadly disease.
Nancy Brinker, a member of the University of Illinois’ Class of 1968, has defined LiveB1G for more than 30 years. In 1980, Brinker lost her sister, Susan Komen, to breast cancer. Brinker promised her sister that she would work to rid the world of the terrible disease. That promise became action, and the Susan G Komen for the Cure Organization was born in 1982. In more than 30 years of fundraising, raising awareness and funding of research, the organization has made an enormous impact. Komen for the Cure has raised more than $2 billion, investing more than $790 million dollars